Isolated limb perfusion for melanoma: Effectiveness and toxicity of cisplatin compared with that of melphalan and other drugs

[1]  M. Santinami,et al.  Isolation perfusion of the lower limb with platinum , 1988, World Journal of Surgery.

[2]  A. Eggermont,et al.  Application of hyperthermia in regional isolated perfusion for melanoma of the limbs , 1992 .

[3]  E. Woltering,et al.  Phase I‐II trial of hyperthermic isolated limb perfusion with cisplatin in the treatment of high risk malignant melanoma of the extremities , 1991, Melanoma research.

[4]  C. Balch,et al.  Isolated limb perfusion for localized melanoma of the extremity. A matched comparison of wide local excision with isolated limb perfusion and wide local excision alone. , 1990, Archives of surgery.

[5]  D. Liénard,et al.  Results of 206 isolated limb perfusions for malignant melanoma. , 1989, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[6]  N. Cascinelli,et al.  Seven years experience with hyperthermic perfusions in extracorporeal circulation for melanoma of the extremities , 1989, Journal of surgical oncology.

[7]  A. V. van Geel,et al.  Functional morbidity after regional isolated perfusion of the limb for melanoma , 1989, Cancer.

[8]  J. Cohen,et al.  Pharmacokinetics, toxicity, and short-term results of cisplatin hyperthermic isolated limb perfusion for soft-tissue sarcoma and melanoma of the extremities. , 1988, American journal of surgery.

[9]  W J Lorenz,et al.  Impact of hyperthermic regional perfusion therapy on cell metabolism of malignant melanoma monitored by 31P MR spectroscopy. , 1988, Magnetic resonance imaging.

[10]  B. Kroon,et al.  Regional isolation perfusion in melanoma of the limbs; accomplishments, unsolved problems, future. , 1988, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[11]  H. Stützer,et al.  The role of regional hyperthermic cytostatic perfusion in the treatment of extremity melanoma , 1988, Cancer.

[12]  J. Roseman.  Effective management of extremity cancers using cisplatin and etoposide in isolated limb perfusions , 1987, Journal of surgical oncology.

[13]  N. Cascinelli,et al.  Hyperthermic antiblastic perfusion with DTIC in stage IIIA-IIIAB melanoma of the extremities. , 1987, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[14]  G. Ben‐Ari,et al.  Isolation perfusion with cisplatin for malignant melanoma of the limbs , 1987, Cancer.

[15]  J. Fortner,et al.  Regional isolated limb perfusion of melanoma intransit metastases using mechlorethamine (nitrogen mustard). , 1986, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[16]  G. Johnston,et al.  Toxicity and complications of vascular isolation and hyperthermic perfusion with lmidazole carboxamide (DTIC) in melanoma , 1986, Cancer.

[17]  E. Krementz,et al.  Regional perfusion: Current sophistication, what next? , 1986 .

[18]  L. Illig,et al.  Die isolierte hypertherme Extremitätenperfusion mit Vindesin, Dacarbazin und Cis-Platin bei der Behandlung maligner Melanome , 1984 .

[19]  S. Ariyan,et al.  Regional isolated perfusion of high risk melanoma of the extremities with imidazole carboxamide. , 1984, Surgery, gynecology & obstetrics.

[20]  M. Nahabedian,et al.  Experimental hyperthermic isolation-perfusion using cis-diamminedichloroplatinum(II). , 1983, Cancer research.

[21]  K. Aigner,et al.  Peripheral nerve damage following isolated extremity perfusion with cis-platinum. , 1983, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.

[22]  K. Aigner,et al.  Regional perfusion with cis-platinum and dacarbazine. , 1983, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.

[23]  E. V. van Slooten,et al.  Dosimetry in isolation perfusion of the limbs by assessment of perfused tissue volume and grading of toxic tissue reactions. , 1982, European journal of cancer & clinical oncology.

[24]  K. Aigner,et al.  Levels of Cis-Platinum in hyperthermic isolated perfusion. , 1982, Anticancer Research.

[25]  H. Koops,et al.  Hyperthermic regional perfusion with melphalan and a combination of melphalan and actinomycin D in the treatment of locally metastasized malignant melanomas of the extremities , 1982, Journal of surgical oncology.

[26]  M. Didolkar,et al.  Regional perfusion for melanoma of the extremities , 1982 .

[27]  E. Copeland,et al.  Regional chemotherapy by isolation-perfusion. , 1978, International advances in surgical oncology.

[28]  B. Giovanella,et al.  Selective lethal effect of supranormal temperatures on human neoplastic cells. , 1976, Cancer research.

[29]  Golomb Fm.  Perfusion of melanoma. 133 isolated perfusions in 114 patients. , 1976 .

[30]  K. R. Cox.  Survival after regional perfusion for limb melanoma. , 1975, The Australian and New Zealand journal of surgery.

[31]  C. Heidelberger,et al.  Selective heat sensitivity of cancer cells. Biochemical and clinical studies. , 1967, Cancer.

[32]  J. Stehlin,et al.  Regional chemotherapy for cancer: experiences with 116 perfusions. , 1960, Annals of surgery.

[33]  R. F. Ryan,et al.  Chemotherapy of Cancer: Regional Perfusion Utilizing an Extracorporeal Circuit , 1958, Annals of surgery.